Distributors / Reps

Find out how IMDA can help you achieve excellence in specialty sales and marketing.

Service Members

Find out how you can sell your service to IMDA members

  • Access to all members
  • Build Loyalty by offerring your brand at group discounts

Meet an IMDA Member

Martab Medical

Allendale, NJ

Contact: John Marmo, president, 201-512-1100, ext. 228
Year Established 1966. Founded 50 years ago by Anthony C. Marmo Jr.

Primary specialties: Anesthesia, emergency services, critical care, neonatal, respiratory care and alternate care facilities; also, hospital equipment rental, and asset management products and services.

Biggest challenge in next 12 months:

The market is changing dramatically; companies like Martab Medical that are willing to change with it will find great opportunity. Conversely, companies that are stuck in the past or unclear of their future will have difficulty. Martab Medical has been fortunate, and we have developed both sides of our business – specialty distribution, and hospital equipment rental/asset management services. We recently signed a five-year agreement with Premier for peak-use rental equipment services. To accommodate that contract and others, we have grown to four locations; in the next five years, we will have locations throughout the country. We are developing the ability to nationally scale our regional business.


IMDA eNews   1/04/2017                                                       Subscribe

From IMDA President Don Sizemore:

The IMDA Annual Conference and Manufacturers Forum will start at 3 p.m. on Sunday, July 23, in Chicago, and end at noon on July 25. For the first time, IMDA will hold a combined conference with the Health Industry Representatives Association. Watch IMDA eNews for more details.

 Congressman Erik Paulsen (R-Minn.) introduced legislation on Jan. 3 that would permanently repeal the medical device tax. The Protect Medical Innovation Act would repeal the 2.3 percent excise tax included in President Obama's health care law that applies to the sale of medical device products. Similar legislation was introduced by Congressman Paulsen in previous sessions of Congress. In the 114th Congress, a two-year suspension of the medical device tax passed in both the House and the Senate with bipartisan support and was signed by the President.

The U.S. Food and Drug Administration should work with medical device manufacturers to ensure their products contribute data to the record about their performance, wrote Ashley Thompson, American Hospital Association senior vice president for public policy analysis and development, on Jan. 6, in comments on the FDA's "The Role of Hospitals in Modernizing Evidence Generation for Device Evaluation: Harnessing the Digital Revolution for Surveillance," published in the Federal Register on Oct. 25, 2016. “Almost all medical devices now have a software component,” she said. “As such, they may be able to gather and share data about their performance on an ongoing basis. For example, if a device needs a steady current to function properly, the device could be programmed to track the current and note any anomalies. And, in this age of cyber attacks, devices could, and should, be programmed to provide software security errors or alerts. Such information could be used in ongoing maintenance. And, in the case of an adverse event, performance information gather by the device could help inform investigations into what went wrong, just as an airplane's black box recorder provides information invaluable to investigating crashes." 

The FDA issued a final guidance titled “Factors to Consider Regarding Benefit-Risk in Medical Device Availability, Compliance, and Enforcement,” reports the National Law Review. The guidance is largely unchanged from the draft version released in June. More specifically, the guidance states that the FDA has the authority to limit the availability of violative medical devices and to pursue other compliance and enforcement actions related to violative medical devices. The agency recognizes, however, that to protect and promote public health, decisions regarding these actions should be made while focusing on the impact on patients.

Click here for a free subscription to the weekly IMDA eNews